KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to 0.24.

  • Eli Lilly's Equity Ratio rose 3011.64% to 0.24 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.24, marking a year-over-year increase of 3011.64%. This contributed to the annual value of 0.24 for FY2025, which is 3011.64% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Equity Ratio is 0.24, which was up 3011.64% from 0.21 recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's Equity Ratio peaked at 0.24 during Q4 2025, and registered a low of 0.14 during Q2 2021.
  • Its 5-year average for Equity Ratio is 0.19, with a median of 0.19 in 2024.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 9485.7% in 2021, then tumbled by 2204.62% in 2023.
  • Over the past 5 years, Eli Lilly's Equity Ratio (Quarter) stood at 0.19 in 2021, then rose by 16.08% to 0.22 in 2022, then fell by 22.05% to 0.17 in 2023, then rose by 6.82% to 0.18 in 2024, then surged by 30.12% to 0.24 in 2025.
  • Its Equity Ratio was 0.24 in Q4 2025, compared to 0.21 in Q3 2025 and 0.18 in Q2 2025.